240 related articles for article (PubMed ID: 18940145)
21. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
[TBL] [Abstract][Full Text] [Related]
22. IgG4 Expression in Patients with Eosinophilic Otitis Media.
Takahashi M; Oka A; Kariya S; Gion Y; Sato Y; Iwasaki S; Oyamada S; Matsubara A; Okano M
ORL J Otorhinolaryngol Relat Spec; 2021; 83(3):167-171. PubMed ID: 33691317
[TBL] [Abstract][Full Text] [Related]
23. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
Yoshida N
Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of so called eosinophilic otitis media.
Nagamine H; Iino Y; Kojima C; Miyazawa T; Iida T
Auris Nasus Larynx; 2002 Jan; 29(1):19-28. PubMed ID: 11772486
[TBL] [Abstract][Full Text] [Related]
25. [Characteristics of migrating cells in effusion of the middle ear in patients with "eosinophilic otitis media"].
Tokumaru A; Eguchi T; Watanabe K
Nihon Jibiinkoka Gakkai Kaiho; 2007 Nov; 110(11):713-9. PubMed ID: 18064875
[TBL] [Abstract][Full Text] [Related]
26. IL13 May Play an Important Role in Developing Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media with Severe Asthma.
Shimizu H; Hayashi M; Kato H; Nakagawa M; Imaizumi K; Okazawa M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681869
[TBL] [Abstract][Full Text] [Related]
27. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of eosinophilic otitis media: a systematic review.
Chen T; Ashman PE; Bojrab DI; Johnson AP; Hong RS; Benson B; Svider PF
Acta Otolaryngol; 2021 Jun; 141(6):579-587. PubMed ID: 33825596
[TBL] [Abstract][Full Text] [Related]
29. Dupilumab improves eosinophilic otitis media associated with eosinophilic chronic rhinosinusitis.
Nakashima D; Nakayama T; Minagawa S; Adachi T; Mitsuyama C; Shida Y; Nakajima T; Haruna SI; Matsuwaki Y
Allergol Int; 2023 Oct; 72(4):557-563. PubMed ID: 37061391
[TBL] [Abstract][Full Text] [Related]
30. Proposal of a Treatment Strategy for Eosinophilic Otitis Media Based on Middle Ear Condition.
Esu Y; Iino Y; Masuda M; Kanazawa H; Yoshida N
Otol Neurotol; 2018 Sep; 39(8):e671-e678. PubMed ID: 30113562
[TBL] [Abstract][Full Text] [Related]
31. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
[TBL] [Abstract][Full Text] [Related]
32. Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.
Ueki S; Ohta N; Takeda M; Konno Y; Hirokawa M
Curr Allergy Asthma Rep; 2017 May; 17(5):33. PubMed ID: 28455742
[TBL] [Abstract][Full Text] [Related]
33. [Current in eosinophilic otitis media].
Du YL; Duan QC; Ma FR
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(6):489-492. PubMed ID: 29871294
[TBL] [Abstract][Full Text] [Related]
34. Treatment of eosinophilic otitis media with pegylated interferon-α 2a and 2b.
Neff BA; Voss SG; Carlson ML; O'Brien EK; Butterfield JH
Laryngoscope; 2017 May; 127(5):1208-1216. PubMed ID: 27667784
[TBL] [Abstract][Full Text] [Related]
35. Eosinophilic otitis media is associated with asthma severity and smoking history.
Seo Y; Nonaka M; Tagaya E; Tamaoki J; Yoshihara T
ORL J Otorhinolaryngol Relat Spec; 2015; 77(1):1-9. PubMed ID: 25633710
[TBL] [Abstract][Full Text] [Related]
36. Eosinophilic otitis media: CT and MRI findings and literature review.
Chung WJ; Lee JH; Lim HK; Yoon TH; Cho KJ; Baek JH
Korean J Radiol; 2012; 13(3):363-7. PubMed ID: 22563277
[TBL] [Abstract][Full Text] [Related]
37. Complete Remission of Severe Eosinophilic Otitis Media With Dupilumab: A Case Report.
van der Lans RJL; van Spronsen E; Fokkens WJ; Reitsma S
Laryngoscope; 2021 Dec; 131(12):2649-2651. PubMed ID: 34216146
[TBL] [Abstract][Full Text] [Related]
38. Cochlear implantation in a patient with eosinophilic otitis media.
Iwasaki S; Nagura M; Mizuta K
Eur Arch Otorhinolaryngol; 2006 Apr; 263(4):365-9. PubMed ID: 16328408
[TBL] [Abstract][Full Text] [Related]
39. Use of IL-5 Inhibitor Benralizumab as a Novel Therapy for Eosinophilic Otitis Media: Clinical Capsule and Review of Literature.
Chow K; Cosetti MK
Otol Neurotol; 2020 Feb; 41(2):e238-e240. PubMed ID: 31923159
[TBL] [Abstract][Full Text] [Related]
40. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
Esu Y; Masuda M; Yoshida N
Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
